These results were consistent with a previous study showing that aberrations in ARID1A resulted in limited accessibility to IFN-responsive genes and impaired IFN gene expression in ovarian clear cell carcinoma mouse models30. This evidence concerns the gene IFNA1 and ovarian clear cell cancer.